Clinical Trials In Atlanta

Discover hundreds of clinical trials in Atlanta.
Search clinical trials in Atlanta by condition or phase.

e.g. Respiratory Diseases

Atlanta•Healthy volunteers: No

Filter results

Results: 1,570

A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Recruiting

Phase 2

Sponsor:

CARGO Therapeutics

Location:

Atlanta, Little Rock, Duarte, Los Angelesshow 23 more

Code:

NCT05972720

Conditions

Cancer

Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludarabine (Conditional therapy)

Cyclophosphamide Monohydrate (Conditional therapy)

firi-cel (Experimental drug)

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Cumming, Dothan, Phoenix, Springdaleshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Recruiting

Phase 2

Phase 3

Sponsor:

Gilead Sciences

Location:

Atlanta, Washington, Fort Pierce, Gainesvilleshow 6 more

Code:

NCT02881320

Conditions

HIV-1 Infection

Eligibility Criteria

Sex: All

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

B/F/TAF (Adult Strength)

B/F/TAF (Low Dose)

B/F/TAF (TOS)

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Atlanta, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Recruiting

Phase 2

Phase 3

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Location:

Atlanta, Huntsville, Oceanside, Temeculashow 12 more

Code:

NCT05729373

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SEP-363856

Placebo

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Snellville, Columbus, Escondido, New Havenshow 17 more

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

A Study of NST-6179 in Adult Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Recruiting

Phase 2

Sponsor:

NorthSea Therapeutics B.V.

Location:

Atlanta, Scottsdale, Palo Alto, San Franciscoshow 8 more

Code:

NCT05919680

Conditions

Intestinal Failure Associated Liver Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NST-6179 Part A

NST-6179 Part B

Matched Placebo

Von Willebrand Factor in Pregnancy (VIP) Study

Recruiting

Sponsor:

University of Washington

Location:

Atlanta, Aurora, New Haven, Miamishow 7 more

Code:

NCT04146376

Conditions

Von Willebrand Diseases

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Use of a postpartum diary and additional blood draws

VWF replacement therapy with Wilate

Tranexamic acid

Use of a postpartum diary and additional blood draws.

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting

Phase 2

Phase 3

Sponsor:

Emory University

Location:

Atlanta, Torrance, Jacksonville, Miamishow 23 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

AngelMed Guardian® System PMA Post Approval Study

Recruiting

Sponsor:

Angel Medical Systems

Location:

Atlanta, Mesa, Los Angeles, Orangeshow 10 more

Code:

NCT05412927

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

PMA P150009 AngelMed Guardian® System

e.g. Respiratory Diseases

Atlanta•Healthy volunteers: No

Filter results

Results: 1,570

A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

Recruiting

Phase 2

Sponsor:

CARGO Therapeutics

Location:

Atlanta, Little Rock, Duarte, Los Angelesshow 23 more

Code:

NCT05972720

Conditions

Cancer

Relapsed/Refractory Large B-cell Lymphoma (LBCL)

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Fludarabine (Conditional therapy)

Cyclophosphamide Monohydrate (Conditional therapy)

firi-cel (Experimental drug)

Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer

Recruiting

Phase 1

Phase 2

Sponsor:

Stemline Therapeutics, Inc.

Location:

Cumming, Dothan, Phoenix, Springdaleshow 37 more

Code:

NCT05563220

Conditions

Breast Cancer

Metastatic Breast Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Elacestrant

Alpelisib

Everolimus

Ribociclib

Palbociclib

Study of Bictegravir/Emtricitabine/Tenofovir Alafenamide Fixed Dose Combination in Adolescents and Children With Human Immunodeficiency Virus-1

Recruiting

Phase 2

Phase 3

Sponsor:

Gilead Sciences

Location:

Atlanta, Washington, Fort Pierce, Gainesvilleshow 6 more

Code:

NCT02881320

Conditions

HIV-1 Infection

Eligibility Criteria

Sex: All

Age: 1 - 17

Healthy Volunteers: Not accepted

Interventions

B/F/TAF (Adult Strength)

B/F/TAF (Low Dose)

B/F/TAF (TOS)

Efficacy and Safety of Tezepelumab in Patients With Eosinophilic Esophagitis

Recruiting

Phase 3

Sponsor:

AstraZeneca

Location:

Atlanta, Phoenix, Little Rock, Los Angelesshow 24 more

Code:

NCT05583227

Conditions

Eosinophilic Esophagitis

Eligibility Criteria

Sex: All

Age: 12 - 70+

Healthy Volunteers: Not accepted

Interventions

Tezepelumab

Placebo

A Clinical Study That Will Measure How Well SEP-363856 Works and How Safe it is in Adults With Generalized Anxiety Disorder

Recruiting

Phase 2

Phase 3

Sponsor:

Otsuka Pharmaceutical Development & Commercialization, Inc.

Location:

Atlanta, Huntsville, Oceanside, Temeculashow 12 more

Code:

NCT05729373

Conditions

Generalized Anxiety Disorder

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

SEP-363856

Placebo

A Research Study on How Well Semaglutide Helps Children and Teenagers With Excess Body Weight Lose Weight

Recruiting

Phase 3

Sponsor:

Novo Nordisk A/S

Location:

Snellville, Columbus, Escondido, New Havenshow 17 more

Code:

NCT05726227

Conditions

Obesity

Eligibility Criteria

Sex: All

Age: 6 - 18

Healthy Volunteers: Not accepted

Interventions

Semaglutide

Placebo

A Study of NST-6179 in Adult Subjects With Intestinal Failure-Associated Liver Disease (IFALD).

Recruiting

Phase 2

Sponsor:

NorthSea Therapeutics B.V.

Location:

Atlanta, Scottsdale, Palo Alto, San Franciscoshow 8 more

Code:

NCT05919680

Conditions

Intestinal Failure Associated Liver Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

NST-6179 Part A

NST-6179 Part B

Matched Placebo

Von Willebrand Factor in Pregnancy (VIP) Study

Recruiting

Sponsor:

University of Washington

Location:

Atlanta, Aurora, New Haven, Miamishow 7 more

Code:

NCT04146376

Conditions

Von Willebrand Diseases

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Use of a postpartum diary and additional blood draws

VWF replacement therapy with Wilate

Tranexamic acid

Use of a postpartum diary and additional blood draws.

Endovascular Therapy for Low NIHSS Ischemic Strokes

Recruiting

Phase 2

Phase 3

Sponsor:

Emory University

Location:

Atlanta, Torrance, Jacksonville, Miamishow 23 more

Code:

NCT04167527

Conditions

Cerebral Ischemia

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Immediate mechanical thrombectomy(iMT) using EmboTrap Revascularization Device

Initial medical management (iMM)

AngelMed Guardian® System PMA Post Approval Study

Recruiting

Sponsor:

Angel Medical Systems

Location:

Atlanta, Mesa, Los Angeles, Orangeshow 10 more

Code:

NCT05412927

Conditions

Acute Coronary Syndrome

Eligibility Criteria

Sex: All

Age: 21+

Healthy Volunteers: Not accepted

Interventions

PMA P150009 AngelMed Guardian® System